Cargando…
Dihydromyricetin Inhibited Migration and Invasion by Reducing S100A4 Expression through ERK1/2/β-Catenin Pathway in Human Cervical Cancer Cell Lines
Cervical cancer has a poor prognosis and is the fourth most common cancer among women. Dihydromyricetin (DHM), a flavonoid compound, exhibits several pharmacological activities, including anticancer effects; however, the effects of DHM on cervical cancer have received insufficient research attention...
Autores principales: | Hsin, Min-Chieh, Hsiao, Yi-Hsuan, Chen, Pei-Ni, Lin, Chiao-Wen, Wang, Po-Hui, Yang, Shun-Fa, Lee, Chung-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735508/ https://www.ncbi.nlm.nih.gov/pubmed/36499426 http://dx.doi.org/10.3390/ijms232315106 |
Ejemplares similares
-
Arctiin Inhibits Cervical Cancer Cell Migration and Invasion through Suppression of S100A4 Expression via PI3K/Akt Pathway
por: Lee, Chung-Yuan, et al.
Publicado: (2022) -
Carbonic Anhydrase IX Promotes Human Cervical Cancer Cell Motility by Regulating PFKFB4 Expression
por: Hsin, Min-Chieh, et al.
Publicado: (2021) -
The Potential of Chinese Herbal Medicines in the Treatment of Cervical Cancer
por: Hsiao, Yi-Hsuan, et al.
Publicado: (2019) -
CLEFMA induces intrinsic and extrinsic apoptotic pathways through ERK1/2 and p38 signalling in uterine cervical cancer cells
por: Lee, Chung‐Yuan, et al.
Publicado: (2023) -
Molecular and Cellular Mechanisms of Metformin in Cervical Cancer
por: Chen, Ya-Hui, et al.
Publicado: (2021)